Platelet-Rich Plasma vs. Autologous Blood Injection for Plantar Fasciitis .
Platelet-Rich Plasma vs Autologous Blood Injection to Treat Plantar Fasciitis: A Prospective Randomized, Double-Blinded, Controlled Trial
Foot Ankle Int . 2022 Sep;43(9):1211-1218.Sixty patients with plantar fasciitis were randomized to receive an ultrasound-guided injection of platelet-rich plasma (n=30) or autologous blood product. The outcomes of interest included pain on a Visual Analog Scale (VAS) and the Foot and Ankle Disability Index (FADI), measured at 1, 3 and 6 months. Results revealed no significant differences between the two groups in all outcomes, at all time-points.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
